In Vitro and in Vivo Effect of Deoxycoformycin in Human T Cell Leukemia

  • Alice L. Yu
  • Faith H. Kung
  • Bohdan Bakay
  • William L. Nyhan
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 122B)


The success of anti-cancer chemotherapy is often limited by the toxicity of chemotherapeutic agents toward normal bone marrow cells and other rapidly dividing cells. It is most desirable, but it has been difficult to find anti-cancer agents that are selectively toxic to neoplastic cells. Approaches to the achievement of such chemotherapeutic selectivity were developed out of the recent elucidation of the causal association of severe combined immunodeficiency with hereditary deficiency of adenosine deaminase (ADA) (1,2). ADA, an enzyme that catalyzes the deamination of adenosine and deoxy-adenosine to inosine and deoxy-inosine, is widely distritubed in mammalian tissue (3,4). However, inherited deficiency of ADA activity is associated with selective impairment of lymphoid functions, particularly T cell functions, although the enzyme is virtually absent from all tissues examined (4).


High Pressure Liquid Chromatography Adenosine Deaminase Severe Combine Immunodeficiency Purine Metabolism Drastic Alteration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Giblett, E.R., Anderson, J.E., Cohen, F., Pollara, B., Meuwissen, H.J., 1972. Lancet 2:1067PubMedCrossRefGoogle Scholar
  2. 2.
    Meuwissen, H.J., Pollara, B., Pickering, R.J., 1975, J. Pediatrics 86:169CrossRefGoogle Scholar
  3. 3.
    Adams, A. and Harkness, R.A., 1976. Clinical Exp. Immunol. 26:647–649Google Scholar
  4. 4.
    VanDerWeyden, M.B. and Kelley, W.N., 1976. J. Biol. Chem. 251:5448–5456Google Scholar
  5. 5.
    Hirschhorn, R., Levytska, V., Pollara, B. and Meuwissen, H.J., 1973. Nature (New Biol) 246:200–202CrossRefGoogle Scholar
  6. 6.
    Mitchell, B.S., Mejias, E., Daddona, P.E. and Kelley, W.N., 1978. Proc. Nat. Acad. Sci. USA 75: 5011–5014PubMedCrossRefGoogle Scholar
  7. 7.
    Carson, D.A., Kaye, J. and Seymitter, J.E., 1978. J. Immunol. 121:1726–1731PubMedGoogle Scholar
  8. 8.
    Snyder, F.F., Mendelsohn, J. and Seegmiller, J.E., 1976. J. Clin. Investigation 58:654–666CrossRefGoogle Scholar
  9. 9.
    Bakay, B., Nissinen, E., Sweetman, L., 1978. Anal Biochem. 86:65PubMedCrossRefGoogle Scholar
  10. 10.
    Polmar, S.H., Stern, R.C., Schwartz, A.L., Wetzlen, E.M., Chase, P.A., Hirschhorn, R., 1976. New Eng. J. Med. 295:1337–1343PubMedCrossRefGoogle Scholar
  11. 11.
    Agarwal, R.P., Spector, T. and Parks, R.E., 1977. Biochem. Pharmacol. 26:359–367PubMedCrossRefGoogle Scholar
  12. 12.
    Agarwal, R.P., 1979. Cancer Res. 39:1425–1427PubMedGoogle Scholar
  13. 13.
    Rogles-Brown, T., Widness, J.A., Agarwal, K.C. and Schwartz, R. 1979. Proc. 7th Annual Meeting of Amer. Assoc. Cancer Res. Abstract 340.Google Scholar
  14. 14.
    Coleman, M.S., Donofrio, J., Hutton, J.J., Hahn, L., Dasud, A., Lampkin, B., Dyminski, J., 1978. J. Biol. Chem. 253:1619.PubMedGoogle Scholar
  15. 15.
    Cohen, A., Hirschhorn, R., Horowitz, S.D., Rubenstein, A., Polmar, S.H., Hong, R., Martin, D.W., 1978. Proc. Natl. Acad. Sci. USA. 75:472-PubMedCrossRefGoogle Scholar
  16. 16.
    Moore, E.C. and Huribert, R.B., 1966. J. Biol. Chem. 241:4802–4809PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Alice L. Yu
    • 1
    • 2
  • Faith H. Kung
    • 1
    • 2
  • Bohdan Bakay
    • 1
    • 2
  • William L. Nyhan
    • 1
    • 2
  1. 1.Department of PediatricsUniversity of CaliforniaSan DiegoUSA
  2. 2.University HospitalSan DiegoUSA

Personalised recommendations